Description

Medtronic plc operates as a global medical technology leader, dedicated to the development, manufacturing, and marketing of device-based medical solutions for healthcare systems, physicians, clinical professionals, and patients worldwide. Its Cardiovascular Portfolio delivers a comprehensive range of heart and vascular technologies. This includes implantable cardiac devices such as pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy systems, alongside cardiac ablation tools, insertable cardiac monitors, TYRX products, and advanced software for remote monitoring and patient-centric care. The segment also supplies products for structural heart conditions, featuring aortic and transcatheter pulmonary valves, as well as solutions for surgical valve repair and replacement. Furthermore, it addresses vascular interventions with endovascular stent grafts and accessories, in addition to products for percutaneous coronary interventions and angioplasty balloons. The Medical Surgical Portfolio encompasses an extensive array of surgical instruments and therapies. Offerings include surgical stapling devices, vessel sealing instruments, wound closure materials, electrosurgery devices, and innovative solutions for surgical artificial intelligence and robotic-assisted procedures. This portfolio also covers mechanical devices for hernia repair, mesh implants, and products tailored for gynecology and lung conditions. Additionally, it provides technologies for minimally invasive gastrointestinal and hepatologic diagnostics and treatments, patient monitoring, airway management and ventilation therapies, and renal disease management. Medtronic's Neuroscience Portfolio supports a wide spectrum of medical specialists, including spinal and neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, interventional radiologists, and ear, nose, and throat specialists. It supplies various products, such as energy surgical instruments and advanced systems for image-guided and intra-operative imaging. The portfolio also features robotic guidance systems specifically designed for robot-assisted spinal procedures, alongside therapies addressing vascular conditions affecting the brain. The Diabetes Operating Unit concentrates on delivering solutions for diabetes management, providing insulin pumps, continuous glucose monitoring (CGM) systems, smart insulin pen systems, and associated consumables and supplies. Established in 1949, the company maintains its headquarters in Dublin, Ireland.